Dysfunction of CD8+ T cells around tumor cells leads to occult lymph node metastasis in NSCLC patients
C Li, M Hu, S Cai, G Yang, L Yang, H Jing… - Cancer …, 2024 - Wiley Online Library
Occult lymph node metastasis (OLNM) is one of the main causes of regional recurrence in
inoperable N0 non‐small cell lung cancer (NSCLC) patients following stereotactic ablation …
inoperable N0 non‐small cell lung cancer (NSCLC) patients following stereotactic ablation …
[HTML][HTML] Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy
A central problem in cancer immunotherapy with immune checkpoint blockade (ICB) is the
development of resistance, which affects 50% of patients with metastatic melanoma 1, 2. T …
development of resistance, which affects 50% of patients with metastatic melanoma 1, 2. T …
[HTML][HTML] Metabolic plasticity of T cell fate decision
The efficacy of adaptive immune responses in cancer treatment relies heavily on the state of
the T cells. Upon antigen exposure, T cells undergo metabolic reprogramming, leading to …
the T cells. Upon antigen exposure, T cells undergo metabolic reprogramming, leading to …
Enhancing the Treating Efficacy of Immunotherapy through the Restructure of Tumor Microenvironment
B Gong, W Jia, Y Zhou, Y Xu, Y Wei… - Advanced NanoBiomed …, 2023 - Wiley Online Library
The therapeutic modes of cancers have been profoundly renovated by immunotherapies,
which have shown extraordinary treating efficacy in certain tumor entities. However, the …
which have shown extraordinary treating efficacy in certain tumor entities. However, the …
[HTML][HTML] CD4+ T cells are homeostatic regulators during Mtb reinfection
JD Bromley, SKC Ganchua, SK Nyquist, P Maiello… - bioRxiv, 2023 - ncbi.nlm.nih.gov
Immunological priming–either in the context of prior infection or vaccination–elicits protective
responses against subsequent Mycobacterium tuberculosis (Mtb) infection. However, the …
responses against subsequent Mycobacterium tuberculosis (Mtb) infection. However, the …
Extra-islet expression of islet antigen boosts T-cell exhaustion to prevent autoimmune diabetes
C Selck, G Jhala, D De George, CTJ Kwong… - bioRxiv, 2023 - biorxiv.org
Persistent antigen exposure results in the differentiation of functionally impaired, also termed
exhausted, T cells which are maintained by a distinct population of precursors of exhausted …
exhausted, T cells which are maintained by a distinct population of precursors of exhausted …
Haem toxicity in the aged spleen impairs T-cell immunity through iron deprivation
N Ron-Harel, D Ezuz, H Ombashe, L Wattad, O atar - bioRxiv, 2024 - biorxiv.org
Ageing profoundly impacts T cell immunity, compromising vaccine responses, susceptibility
to infections, and immunosurveillance. Mechanisms of T cell ageing involve cell-intrinsic …
to infections, and immunosurveillance. Mechanisms of T cell ageing involve cell-intrinsic …
[PDF][PDF] CD39 的临床意义及其与肝癌浸润T 细胞耗竭的相关性分析
肖淑秀, 林志远, 宋正清, 姚梦菲… - Progress in Modern …, 2023 - biomed.cnjournals.com
摘要目的: 探索CD39 分子(编码基因ENTPD1) 在原发性肝细胞肝癌(Hepatocellular carcinoma,
HCC) 中的表达, 临床意义及其与HCC 中免疫浸润和T 细胞耗竭的相关性. 方法: TIMER, GEPIA …
HCC) 中的表达, 临床意义及其与HCC 中免疫浸润和T 细胞耗竭的相关性. 方法: TIMER, GEPIA …
Somatic evolution of Cancer: A new synthesis
U Baing, R Kharate, M Watve - 2023 - preprints.org
Cancers have been interpreted either as somatic evolution of cheater cells that escape
replication regulation or alternatively as non-healing wounds. Both the interpretations have …
replication regulation or alternatively as non-healing wounds. Both the interpretations have …
Durability of Response with First-Line Combined Immune Checkpoint Inhibitor Therapy Compared to Checkpoint Inhibitor with VEGFR-TKI in Advanced Clear Cell …
J Zaemes, DF McDermott, MM Regan… - Kidney …, 2024 - content.iospress.com
Over the past several years, four regimens incorporating immune checkpoint inhibitors have
become widely used in the front-line setting to treat metastatic clear cell renal cell …
become widely used in the front-line setting to treat metastatic clear cell renal cell …